TGFB1 and COVID-19: In particular, the dysregulation of the TGF-β signaling pathway triggers an extensive immune reaction, leading to immense pulmonary damage and TGF-β levels in infected individuals and may thus predict poor outcomes in patients with COVID-19 [48,49].